Literature DB >> 29373197

The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer.

Saeed Farajzadeh Valilou1, Mahsa Keshavarz-Fathi2, Nicola Silvestris3, Antonella Argentiero4, Nima Rezaei5.   

Abstract

Pancreatic cancer is considered as one of the most lethal types of cancer due to its poor prognosis and lack of effective therapeutic approaches. Although many studies have been done on pancreatic cancer, the current treatment methods did not exhibit successful results. Hence, novel strategies are needed for treatment of pancreatic cancer. The microenvironment of pancreatic cancer contains many factors such as inflammatory cytokines and tumor associated macrophages (TAMs), which influence the tumor's status. These factors can be upregulated and consequently lead to exacerbation of tumor progression. Understanding the role of pro- and anti-inflammatory cytokines and the function of TAMs in the pancreatic cancer microenvironment might lead to development and improvement of novel strategies in the diagnosis and treatment of pancreatic cancer and may result in promising treatments for this type of cancer.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Inflammatory cytokines; Interleukin; Pancreatic cancer; Tumor associated macrophages; Tumor microenvironment; Tumor necrosis factor-alpha

Mesh:

Substances:

Year:  2018        PMID: 29373197     DOI: 10.1016/j.cytogfr.2018.01.007

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  41 in total

Review 1.  Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site.

Authors:  Elaheh Nasrollahzadeh; Sepideh Razi; Mahsa Keshavarz-Fathi; Massimiliano Mazzone; Nima Rezaei
Journal:  Cancer Immunol Immunother       Date:  2020-06-04       Impact factor: 6.968

Review 2.  Tumor-associated macrophages: role in cancer development and therapeutic implications.

Authors:  Arash Salmaninejad; Saeed Farajzadeh Valilou; Arash Soltani; Sepideh Ahmadi; Yousef Jafari Abarghan; Rhonda J Rosengren; Amirhossein Sahebkar
Journal:  Cell Oncol (Dordr)       Date:  2019-05-29       Impact factor: 6.730

Review 3.  Causal contributors to tissue stiffness and clinical relevance in urology.

Authors:  Laura Martinez-Vidal; Valentina Murdica; Chiara Venegoni; Filippo Pederzoli; Marco Bandini; Andrea Necchi; Andrea Salonia; Massimo Alfano
Journal:  Commun Biol       Date:  2021-08-26

4.  Methylation of immune-regulatory cytokine genes and pancreatic cancer outcomes.

Authors:  Brian Z Huang; Alexandra M Binder; Catherine A Sugar; Chun R Chao; Veronica Wendy Setiawan; Zuo-Feng Zhang
Journal:  Epigenomics       Date:  2020-09-01       Impact factor: 4.778

5.  Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression.

Authors:  Ye Bi; Venktesh S Shirure; Ruiyang Liu; Cassandra Cunningham; Li Ding; J Mark Meacham; S Peter Goedegebuure; Steven C George; Ryan C Fields
Journal:  Integr Biol (Camb)       Date:  2020-09-30       Impact factor: 2.192

6.  DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization.

Authors:  Courtney W Houchen; Parthasarathy Chandrakesan; Janani Panneerselvam; Randal May; Nathaniel Weygant; Dongfeng Qu; William R Berry; Kamille Pitts; Ben Z Stanger; Chinthalapally V Rao; Michael S Bronze
Journal:  Mol Cancer Ther       Date:  2020-05-05       Impact factor: 6.261

7.  NAD+ depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibition.

Authors:  Alexandra M Moore; Lei Zhou; Jing Cui; Luyi Li; Nanping Wu; Alice Yu; Soumya Poddar; Keke Liang; Evan R Abt; Stephanie Kim; Razmik Ghukasyan; Nooneh Khachatourian; Kristina Pagano; Irmina Elliott; Amanda M Dann; Rana Riahi; Thuc Le; David W Dawson; Caius G Radu; Timothy R Donahue
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-23       Impact factor: 11.205

8.  Inflammatory Cell Death, PANoptosis, Mediated by Cytokines in Diverse Cancer Lineages Inhibits Tumor Growth.

Authors:  R K Subbarao Malireddi; Rajendra Karki; Balamurugan Sundaram; Balabhaskararao Kancharana; SangJoon Lee; Parimal Samir; Thirumala-Devi Kanneganti
Journal:  Immunohorizons       Date:  2021-07-21

Review 9.  The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives.

Authors:  Shun Wang; Yan Zheng; Feng Yang; Le Zhu; Xiao-Qiang Zhu; Zhe-Fang Wang; Xiao-Lin Wu; Cheng-Hui Zhou; Jia-Yan Yan; Bei-Yuan Hu; Bo Kong; De-Liang Fu; Christiane Bruns; Yue Zhao; Lun-Xiu Qin; Qiong-Zhu Dong
Journal:  Signal Transduct Target Ther       Date:  2021-07-05

Review 10.  Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer.

Authors:  Ramiz S Ahmad; Timothy D Eubank; Slawomir Lukomski; Brian A Boone
Journal:  Biomolecules       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.